Gaining a granular understanding of the patient journey is essential for life sciences commercialization in today’s patient-centric environment. This insight shapes everything from product development to market access and post-launch management.

However, patient journey efforts are often fragmented, with different teams using varied methodologies and data sources, limiting the ability to gain a comprehensive view of the barriers and drivers affecting brands.

At Strat Bio Partners, we are reimagining the approach to mapping patient journey touchpoints. Our goal is to capture a broader and more detailed perspective, enabling our customers to better serve their own customers.